Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer

INTRODUCTION: HER2 overexpression, or rather HER2 gene amplification, is indicative for Herceptin therapy in both metastatic and pre-metastatic breast cancer patients. Patient's individual sensitivity to Herceptin treatment, however, varies enormously and spans from effectual responsiveness ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Sassen, Andrea, Diermeier-Daucher, Simone, Sieben, Manuela, Ortmann, Olaf, Hofstaedter, Ferdinand, Schwarz, Stephan, Brockhoff, Gero
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750111/
https://www.ncbi.nlm.nih.gov/pubmed/19624808
http://dx.doi.org/10.1186/bcr2339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750111/
https://www.ncbi.nlm.nih.gov/pubmed/19624808
http://dx.doi.org/10.1186/bcr2339

Ejemplares similares